Articles

All Clinical Trials Community Diagnostics Foundation News Gene Therapy Historical Research Therapeutics

From Sydney to New York: MEF2C Foundation Australia Leads the Global Charge

MEF2C Foundation Australia is at the frontline of the Volare Study, the first longitudinal natural history study for MCHS.

2026-06-09

Foundation News

Milestone Numbers: US MEF2C Foundation Registry Reaches 170 Patients

The US MEF2C Foundation has reached a critical data threshold, with 170 patients now registered in the foundation's registry. This growing longitudinal dataset is fueling the path toward human clinical trials for MEF2C Haploinsufficiency Syndrome.

2026-06-08

Foundation News

Pathways to Hope: MEF2C Foundation UK Surpasses £400K Target

The MEF2C Foundation UK has shattered its fundraising goal during Rare Disease Day 2026, raising over half a million pounds to fund critical clinical trial milestones.

2026-06-07